Traders News Source Initiates Coverage on JanOne Inc. (NASDAQ: JAN), a Biotech Company with a Lead Product to Combat Covid-19
New never seen before, tiny float, recent IPO Report that you do NOT want to miss coming tomorrow 8-7-20 at market open…
Record NASDAQ is Good News for Our Members New never seen before, tiny float, recent IPO Report that you do NOT want to miss coming tomorrow 8-7-20 at...
Our Recently Reported on Stocks Subsequently Featured on “The Claman Countdown” on Fox Business
Three of our Recent Reported on Stocks Were Subsequently Featured on Fox Business. ShiftPixy (NASDAQ: PIXY), Vuzix Corp. (NASDAQ: VUZI) and Arcimoto (...
Potential FDA Approval Just Around the Corner for a Blockbuster Product (Mino-Lok) With Billion-Dollar Market Estimates
Citius Pharma (CTXR) Brings More Experts on Board CTXR looking ready to hit the gas Good day everyone, We are continuing our coverage of Citius Pharma...
The Uber of Employment ShiftPixy, Inc. (NASDAQ: PIXY) Gig Economy, High Growth Report
ShiftPixy (PIXY) Exemplifies Innovation in a Pandemic BREAKING NEWS: ShiftPixy Labs may be a new vertical Good day everyone, We are initiating coverag...
New Featured “High Growth” Report to be Issued 7/30/20 at Market Open
We Found a Tiny Float Gem to Report On New report coming at market open tomorrow 7/30/20 Good day everyone, The Covid 19 pandemic is still a major iss...
Genprex (GNPX), Cancer, Diabetes and Gene Therapy Genprex is now part of the Russell 3000
Good day everyone, We are initiating coverage of Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company involved in developing various ap...
Does Vuzix (VUZI) Have the Next Product in Disruptive Technology?
Traders News Source Feature Report: Does Vuzix (VUZI) Have the Next Product in Disruptive Technology?
Vuzix (VUZI) Gives Details of Aerospace Product Development Deal
There is no doubt that this deal could add millions to Vuzix bottom line as well as lead to more large contracts. Good day everyone, We are continuing...
Initiating Coverage: Producing Products Conducive to Our New Normal, 166 Patents and Growing
Vuzix (VUZI) Breaks Through Moving Averages in a Bullish Manner Vuzix has grown from 90 patents and patents pending to 166, over the last 36 months Go...